Targeting potential of antibody conjugates
- 31 December 1983
- journal article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 23 (1) , 147-177
- https://doi.org/10.1016/0163-7258(83)90029-3
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- Targeting of the antiviral protein from Phytolaccaamericana with an antibodyBiochemical and Biophysical Research Communications, 1982
- Cis-aconityl spacer between daunomycin and macromolecular carriers: A model of pH-sensitive linkage releasing drug from a lysosomotropic conjugateBiochemical and Biophysical Research Communications, 1981
- Daunomycin targeting by antibodies to oncofoetal proteins in vivoInternational Journal of Immunopharmacology, 1980
- Epidermal growth factor-toxin A chain conjugates: EGF-Ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxicCell, 1980
- Preparation of a hybrid of fragment Fab' of antibody and fragment a of diphtheria toxin and its cytotoxicityBiochemical and Biophysical Research Communications, 1979
- Effective antitumour conjugates of alkylating drug and antibody using dextran as the intermediate carrierPublished by Elsevier ,1977
- Selection and characterization of cells resistant to diphtheria toxin and pseudomonas exotoxin A: presumptive translational mutantsCell, 1977
- The cure and concomitant immunization of mice bearing Ehrlich ascites tumors by treatment with an antibody-alkylating agent complexPublished by Elsevier ,1973
- 2,3,5-Tris-et̊hylenimino-1,4-benzoquinone (Trenimon): Some chemical and biological propertiesChemico-Biological Interactions, 1973
- Immunoradioactive agent against cancer.BMJ, 1967